Orakl Oncology raised €11M in a seed funding round led by Singular to launch AI-powered drug development products.
Amount Raised
€11 Million
Round Type
Seed
ParisBiotechnologyHealth CareArtificial IntelligenceMedicalTherapeuticsInvestors
Description
Orakl Oncology has successfully completed a €11M seed funding round intended to support the launch of two new commercial products, O-Predict and O-Validate. The round was led by Singular, with contributions from Bpifrance and existing investors.
Quick answer
Orakl Oncology raised €11 Million in a Seed round, dated December 3, 2024. Investors: Bpifrance and Singular. Orakl Oncology is based in Paris, Ile-de-France, France.
- How much did Orakl Oncology raise?
- Orakl Oncology raised €11 Million in a Seed round on December 3, 2024.
- Who invested in Orakl Oncology?
- Bpifrance and Singular are named as investors in this round.
- What does Orakl Oncology do?
- Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer.
- Where is Orakl Oncology based and how big is it?
- Orakl Oncology is based in Paris, Ile-de-France, France.
- Who are the decision-makers at Orakl Oncology?
- Fundz holds 1 contact at Orakl Oncology. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Orakl Oncology, and when
A new round usually means Orakl Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orakl Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orakl Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orakl Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orakl Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Orakl Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.